SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Nureca gains on getting nod to set up new manufacturing facility in Punjab

22 Apr 2025 Evaluate

Nureca is currently trading at Rs. 250.00, up by 2.55 points or 1.03% from its previous closing of Rs. 247.45 on the BSE.

The scrip opened at Rs. 259.80 and has touched a high and low of Rs. 259.80 and Rs. 245.00 respectively. So far 582 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 447.00 on 20-Jan-2025 and a 52 week low of Rs. 198.00 on 07-Apr-2025.

Last one week high and low of the scrip stood at Rs. 235.70 and Rs. 224.50 respectively. The current market cap of the company is Rs. 250.00 crore.

The promoters holding in the company stood at 64.30%, while Institutions and Non-Institutions held 1.07% and 34.62% respectively.

Nureca has received formal approval from the Government of Punjab, Department of Industries & Commerce (Invest Punjab), for the setting up of a new manufacturing facility in Punjab. This unit will focus on the manufacturing of health and wellness equipment, further strengthening Nureca’s domestic production capabilities and supporting its ‘Make in India’ initiative.

The project has been approved under the Industrial and Business Development Policy (IBDP) 2022, and the company is eligible for various incentives offered by State government under this policy.

Nureca is a B2C company engaged in the business of home healthcare and wellness products, which offers quality, durability, functionality, usability and innovative designs.

Nureca Share Price

233.90 3.90 (1.70%)
10-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Lenskart Solutions 543.30
Poly Medicure 1665.85
Laxmi Dental 219.95
Nureca 233.90
Hemant Surgical Inds 369.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: